Time: 2024-08-09
GLP-1 receptor agonist medications such as Ozempic , Wegovy , and Mounjaro have become increasingly popular among patients with type 2 diabetes and those seeking to manage obesity . However , recent research has highlighted the potential complications that can arise for patients taking these medications when undergoing surgery . Studies have shown that more than half of patients on GLP-1s had significant gastric contents before surgery , which can increase the risk of pulmonary aspiration , a life - threatening condition where food or liquid is inhaled into the lungs.
Doctors and experts have warned about the potential dangers associated with GLP-1 agonists during surgical procedures . Dr. Alfred Bonati from the Bonati Spine Institute in Florida emphasized the importance of patients stopping their medication at least one week before surgery to reduce the risk of complications . Additionally , Dr. Brett Osborn from St. Mary 's Medical Center in Florida highlighted the increased risk of postoperative ileus and bowel ischemia that patients on GLP-1 agonists may face.
One of the critical side effects of GLP-1 agonists like Ozempic is the slowing down of digestion , which can lead to food staying in the stomach for longer periods . This can pose a significant risk during surgery , as it may increase the likelihood of pulmonary aspiration . To mitigate these risks , healthcare experts recommend consulting with your doctor and adjusting the medication dosage before undergoing any surgical procedures.
It is essential for patients to discuss their medication regimen with their surgeon and anesthesiologist before surgery to ensure a safe and successful procedure . By following the advice of healthcare providers and adhering to pre - operative fasting protocols , patients can minimize the potential complications associated with GLP-1 agonists . Proper nutrition and careful monitoring of medication dosages are crucial for patients taking these medications to ensure a smooth recovery post - surgery.
Business
